Diakron Pharmaceuticals, Inc.
Records under this name other than patents Diakron Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Diakron Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,016,417 | Extended Release Formulation of a Direct Thrombin Inhibitor Lapsed on the fee record Ended Jul 10, 2022 · High confidence | Lapsed on the fee record | Ended Jul 10, 2022 | High confidence |
| US 8,541,580 | Process for the Preparation of Pyrazinone Thrombin Inhibitor and Its Intermediates Lapsed on the fee record Ended Sep 24, 2021 · High confidence | Lapsed on the fee record | Ended Sep 24, 2021 | High confidence |
| US 7,338,941 | Pharmaceutical Compositions for Lowering Blood Glucose and Blood Cholesterol Levels Lapsed on the fee record Ended Mar 4, 2020 · High confidence | Lapsed on the fee record | Ended Mar 4, 2020 | High confidence |
| US 8,106,062 | Calcium Channel Blockers Lapsed on the fee record Ended Jan 31, 2020 · High confidence | Lapsed on the fee record | Ended Jan 31, 2020 | High confidence |
| US 7,815,946 | Anti-diabetic and cholesterol lowering preparation from fenugreek seeds Lapsed on the fee record Ended Oct 19, 2014 · USPTO record | Lapsed on the fee record | Ended Oct 19, 2014 | USPTO record |